Financial Statements Notes to the Financial Statements 32. FINANCIAL INSTRUMENTS (continued) (vi) Market risk (continued) (b) Interest rate risk (continued) Exposure to interest rate risk The interest rate profile of the Group’s and the Company’s significant interest-bearing financial instruments, based on carrying amounts as at the end of the reporting period are as follows: Group Company 2024 2023 2024 2023 RM’mil RM’mil RM’mil RM’mil Fixed rate instruments Fixed deposits 975 1,507 – – Bank loans (516) (774) – – Fixed rate medium term notes (510) (580) – – Loans from corporates (32) (8) – – Variable rate instruments Bank overdrafts (83) (78) – – Bank loans (6,121) (5,974) – – Redeemable non-convertible debentures (819) – – – Floating rate medium term notes (3,993) – – – Loans from corporates (935) (976) – – Provision for loan taken by a joint venture – (39) – – Derivative instruments Interest rate caps* 1,031 1,129 – – Interest rate swaps* 1,455 993 – – Cross currency interest rate swaps* 271 286 – – * Based on nominal value as at the end of the reporting period. Sensitivity analysis Fair value sensitivity analysis for fixed rate instruments The Group does not account for any fixed rate financial assets and liabilities at FVTPL. Therefore, a change in interest rates at the end of the reporting period would not affect profit or loss. Cash flow sensitivity analysis for variable rate instruments A change of 100 basis points (“bp”) in interest rates at the end of the reporting period would not have a material impact on the profit or loss or equity of the Group. IHH Healthcare Berhad | Annual Report 2024 202
RkJQdWJsaXNoZXIy NDgzMzc=